FTSJD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.659700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.738600E-01
Normal-vs-Stage2
8.622500E-02
Normal-vs-Stage3
1.584610E-01
Normal-vs-Stage4
7.949200E-01
Stage1-vs-Stage2
7.327800E-01
Stage1-vs-Stage3
1.096250E-02
Stage1-vs-Stage4
7.007200E-01
Stage2-vs-Stage3
3.479700E-02
Stage2-vs-Stage4
6.100200E-01
Stage3-vs-Stage4
2.178200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.927500E-02
Normal-vs-AfricanAmerican
5.321800E-01
Normal-vs-Asian
1.089360E-01
Caucasian-vs-AfricanAmerican
2.948000E-01
Caucasian-vs-Asian
4.024200E-01
AfricanAmerican-vs-Asian
2.210800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.605600E-02
Normal-vs-Female
1.082590E-01
Male-vs-Female
5.928800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.813600E-01
Normal-vs-Age(41-60Yrs)
2.647800E-01
Normal-vs-Age(61-80Yrs)
4.137700E-02
Normal-vs-Age(81-100Yrs)
2.190600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.107400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.789600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.766600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.394150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.037000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.916300E-02
Normal-vs-Daily Drinker
5.539800E-02
Normal-vs-Weekly Drinker
4.607600E-02
Normal-vs-Occasional Drinker
2.553800E-01
Normal-vs-Social Drinker
1.856580E-01
Non Drinker-vs-Daily Drinker
2.668000E-01
Non Drinker-vs-Weekly Drinker
2.880600E-01
Non Drinker-vs-Occasional Drinker
2.064800E-01
Non Drinker-vs-Social Drinker
5.000000E-01
Daily Drinker-vs-Weekly Drinker
9.787200E-01
Daily Drinker-vs-Occasional Drinker
3.816300E-02
Daily Drinker-vs-Social Drinker
1.288040E-01
Weekly Drinker-vs-Occasional Drinker
3.906300E-02
Weekly Drinker-vs-Social Drinker
1.219390E-01
Occasional Drinker-vs-Social Drinker
6.191400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.530200E-02
Normal-vs-Grade 2
3.519200E-03
Normal-vs-Grade 3
8.278100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.537600E-01
Grade 1-vs-Grade 3
3.356100E-02
Grade 1-vs-Grade 4
5.530200E-02
Grade 2-vs-Grade 3
7.154000E-02
Grade 2-vs-Grade 4
3.519200E-03
Grade 3-vs-Grade 4
8.278100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.941770E-02
Normal-vs-NonDiabetic
7.631800E-02
Diabetic-vs-NonDiabetic
8.148300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.421700E-02
Normal-vs-NoPancreatitis
6.736200E-02
Pancreatitis-vs-NoPancreatitis
2.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.472000E-02
Normal-vs-N1
1.039170E-01
N0-vs-N1
3.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.663200E-01
Normal-vs-TP53-NonMutant
1.941600E-01
TP53-Mutant-vs-TP53-NonMutant
5.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
